HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Non-Receptor Type 11 Protein Tyrosine Phosphatase

A subtype of non-receptor protein tyrosine phosphatases that contain two SRC HOMOLOGY DOMAINS. Mutations in the gene for protein tyrosine phosphatase, non-receptor type 11 are associated with NOONAN SYNDROME.
Also Known As:
Protein Tyrosine Phosphatase, Non-Receptor Type 11; Phosphotyrosine Phosphatase Syp; Protein Tyrosine Phosphatase PTP3; Protein-Tyrosine-Phosphatase 2C; SHP-2 Protein-Tyrosine Phosphatase; SHP2 Phosphatase; SHPTP2; Shp-2 Tyrosine Phosphatase; Phosphatase, SHP2; Protein Tyrosine Phosphatase 2C; Protein Tyrosine Phosphatase, Non Receptor Type 11; Shp 2 Tyrosine Phosphatase; Tyrosine Phosphatase, Shp-2
Networked: 138 relevant articles (2 outcomes, 8 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Feng, Gen-Sheng: 11 articles (01/2020 - 05/2011)
2. Neel, Benjamin G: 8 articles (01/2021 - 01/2007)
3. Birchmeier, Walter: 6 articles (01/2022 - 07/2007)
4. Sun, Yang: 5 articles (03/2022 - 04/2014)
5. Hatakeyama, Masanori: 5 articles (06/2008 - 12/2005)
6. Cheng, Hongqiang: 4 articles (03/2022 - 06/2012)
7. Ke, Yuehai: 4 articles (03/2022 - 06/2012)
8. Zhang, Xue: 4 articles (03/2022 - 06/2012)
9. Xu, Qiang: 3 articles (03/2022 - 03/2019)
10. Zhu, Yuyu: 3 articles (03/2022 - 03/2019)

Related Diseases

1. Neoplasms (Cancer)
2. Glaucoma
3. Noonan Syndrome (Female Pseudo-Turner Syndrome)
4. Breast Neoplasms (Breast Cancer)
5. Acute Myeloid Leukemia (Acute Myelogenous Leukemia)

Related Drugs and Biologics

1. Retinaldehyde (Retinal)
2. Nucleotides
3. Guanosine Triphosphate (GTP)
4. Tyrosine (L-Tyrosine)
5. Proteins (Proteins, Gene)
6. src-Family Kinases
7. Focal Adhesion Kinase 1
8. Focal Adhesion Protein-Tyrosine Kinases
9. Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)
10. Protein Tyrosine Phosphatases

Related Therapies and Procedures

1. Therapeutics
2. Drug Therapy (Chemotherapy)
3. Immunotherapy
4. Aftercare (After-Treatment)